Categories: Sports

Urs Lehmann appointed CEO of FIS

Urs Lehmann will continue his commitment to snow sports in a new role starting at the FIS Technical Committee Autumn Meetings at the end of September. The 56-year-old Swiss will become the first CEO of FIS.

- Advertisement -

“We are delighted that Urs will join the FIS leadership,” says FIS President Johan Eliasch and FIS Secretary General Michel Vion.

- Advertisement -
After the very positive development of our collaboration, we have decided to join forces in leading FIS into the future.
Urs Lehmann
Strengthening our leadership with Urs is an important step in ensuring that we are in the best possible place to tackle the major challenges that lie ahead in the coming years.
Johan Eliasch, FIS President

Urs Lehmann was an active ski racer until 1997, with the 1993 downhill world championship title in Morioka as the highlight of his career. A Doctor of Economics, he was elected President of Swiss-Ski in 2008, a position he is now stepping down from. Under Urs Lehmann’s strategic leadership, Swiss-Ski developed into a highly successful association in both sporting and economic terms. Urs Lehmann was a member of the FIS Council from 2021 to 2024. From 2009 to 2024, he was CEO of the pharmaceutical manufacturer Similasan, and since 2024 he has been Chairman of the Board of Directors of the Similasan Group.

- Advertisement -
TheNewsMarketTeam

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

8 hours ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

6 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago